betahistine actavis tablett
teva b.v. - beetahistiin - tablett - 8mg 120tk; 8mg 100tk; 8mg 30tk; 8mg 50tk
uplizna
horizon therapeutics ireland dac - inebilizumab - neuromyelitis optica - immunosupressandid - uplizna is indicated as monotherapy for the treatment of adult patients with neuromyelitis optica spectrum disorders (nmosd) who are anti-aquaporin 4 immunoglobulin g (aqp4-igg) seropositive (see section 5.
isopto-atropine silmatilgad
alcon - atropiin - silmatilgad - 10mg 1ml 5ml 1tk
isopto carpine silmatilgad, lahus
alcon-couvreur - pilokarpiin - silmatilgad, lahus - 20mg 1ml 15ml 1tk; 20mg 1ml 10ml 1tk
opticlox eye ointment silmasalv
norbrook laboratories limited - kloksatsilliin - silmasalv - 835mg 5g 5g 1tk
viroptic silmatilgad, lahus
dsm pharmaceuticals inc. - trifluridiin - silmatilgad, lahus - 1% 7.5ml 1tk
pyostacine õhukese polümeerikattega tablett
sanofi s.r.l. - pristinamütsiin - õhukese polümeerikattega tablett - 500mg 16tk
enspryng
roche registration gmbh - satralizumab - neuromyelitis optica - immunosupressandid - satralizumab (enspryng) is indicated as a monotherapy or in combination with immunosuppressive therapy (ist) for the treatment of neuromyelitis optica spectrum disorders (nmosd) in adult and adolescent patients from 12 years of age who are anti-aquaporin-4 igg (aqp4-igg) seropositive.
simbrinza
novartis europharm limited - brinsolamiidi, brimonidine tartraat - ocular hypertension; glaucoma, open-angle - oftalmoloogilised vahendid - kõrge silmasisese rõhu (iop) vähenemine avatud nurga glaukoomi või okulaarse hüpertensiooniga täiskasvanud patsientidel, kellel monoteraapia annab iop-i vähesuse.
montelukast synthon 10 mg õhukese polümeerikattega tablett
synthon b.v. - montelukast - õhukese polümeerikattega tablett - 10mg 7tk